Literature DB >> 21360268

Perianal lymphoma presenting as an abscess in a heterosexual and nonimmunocompromised patient: report of a case.

Muhittin Yaprak1, Gulsum Ozlem Elpek, Okan Erdogan.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 21360268     DOI: 10.1007/s12029-011-9270-4

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  8 in total

Review 1.  Perianal lymphoma in a heterosexual and nonimmunocompromised patient: report of a case and review of the literature.

Authors:  D L Smith; P A Cataldo
Journal:  Dis Colon Rectum       Date:  1999-07       Impact factor: 4.585

Review 2.  Management of gastrointestinal lymphoma.

Authors:  Leonidas G Koniaris; George Drugas; Philip J Katzman; Rabih Salloum
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

3.  Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis.

Authors:  I M DAWSON; J S CORNES; B C MORSON
Journal:  Br J Surg       Date:  1961-07       Impact factor: 6.939

Review 4.  EBV-associated anorectal lymphomas in patients with acquired immune deficiency syndrome.

Authors:  H L Ioachim; C Antonescu; F Giancotti; B Dorsett; M A Weinstein
Journal:  Am J Surg Pathol       Date:  1997-09       Impact factor: 6.394

5.  Primary lymphoma of the anal canal presenting as perianal suppuration.

Authors:  R J Steele; O Eremin; A S Krajewski; G L Ritchie
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

6.  Anal lymphoma presenting as a perianal abscess.

Authors:  A J Porter; A P Meagher; J L Sweeney
Journal:  Aust N Z J Surg       Date:  1994-04

7.  Primary colorectal lymphoma.

Authors:  C W Fan; C R Changchien; J Y Wang; J S Chen; K C Hsu; R Tang; J M Chiang
Journal:  Dis Colon Rectum       Date:  2000-09       Impact factor: 4.585

Review 8.  Management of less common tumors of the colon, rectum, and anus.

Authors:  Madison Cuffy; Farshad Abir; Walter E Longo
Journal:  Clin Colorectal Cancer       Date:  2006-01       Impact factor: 4.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.